MDMA

3,4-Methylenedioxymethamphetamine

Formula: C₁₁H₁₅NO₂

Drug class: Empathogen–entactogen; stimulant

Other names: MDMA, Ecstasy, E, X, XTC, Molly

Onset of action: 30–45 minutes (orally)

Peak: 1.5 to 2 hours

Read our Research

Research Resources

MDMA treatment manual, Investigator’s Brochure (IB), Developmental Safety Update Report (DSUR), accounts of healing, and other important resources and information on MDMA.

Posttraumatic Stress Disorder (PTSD)

PTSD is a chronic, debilitating mental health disorder that occurs following a traumatic event.

Eating Disorders

Eating disorders are characterized by disturbances in behaviors, thoughts and attitudes to food, eating, and body weight or shape.

Anxiety disorder studies

Studies to determine the effects of MDMA on social anxiety in autistic adults and anxiety associated with life-threatening illnesses.

Investigator-initiated trials

Unique clinical trials sponsored and implemented by clinicians to investigate a specific research question they have interest in furthering within their field

Healthy Volunteer studies

Studies to determine the effects of MDMA in healthy individuals without a specific disorder.

Ways to Participate

Participate in MDMA Study

MDMA Therapist Training

  • FDA has designated MDMA-assisted therapy for PTSD a Breakthrough Therapy.
  • MAPS’ Phase 3 clinical trial of MDMA-assisted therapy demonstrated statistically significant improvement in PTSD symptoms after three sessions.
  • MDMA has been administered to approximately 1,700 human subjects with only one serious adverse reaction.

Did you know?

THE DROP

See what’s happening in today’s MDMA news.

MAPS, MDMA & Beyond Webinar

July 12, 2024
Join MAPS leaders Kris Lotlikar, Ismail Ali, J.D., Allison Coker, Ph.D., and Betty Aldworth to delve into the approaches and strategies MAPS is engaging during this critical juncture. After 38 years of …
Read more
All MDMA News